Health Insurance
The five largest U.S. health insurers — UnitedHealth Group, Elevance (Anthem), CVS-Aetna, Cigna, and Humana — collect more than a trillion dollars in annual premiums and spend tens of millions lobbying Congress to protect the employer-based insurance model, block Medicare-for-All proposals, and expand the privatized Medicare Advantage program. Distinct from pharmaceutical manufacturers, the insurance lobby focuses on payment rules, prior authorization, denial practices, and the rate-setting fights that determine how much they pay providers and how much patients owe.
Party Breakdown
Top 10 Recipients
No tracked funding data available for this industry yet.
Frequently Asked Questions
How is the health insurance lobby different from Big Pharma?
Pharma manufactures and prices drugs; health insurers pay (or refuse to pay) for them. The two lobbies often fight each other — insurers want lower drug prices and broader negotiation, pharma wants higher prices and patent protection. Insurers (via AHIP and individual companies like UnitedHealth and Cigna) lobby primarily on payment rules, Medicare Advantage rates, prior authorization, and the structure of the Affordable Care Act marketplaces.
Why does the industry fight Medicare-for-All?
A single-payer system would eliminate the private health insurance market entirely — a roughly $1.3 trillion annual industry. AHIP (the trade group), UnitedHealth, Elevance, and Cigna have funded multi-million dollar campaigns including the Partnership for America's Health Care Future to brand single-payer as 'government-run healthcare' and to defend the employer-sponsored model. Members of the Senate Finance and House Energy and Commerce committees receive the bulk of insurer contributions.
What is Medicare Advantage and why is it lucrative for insurers?
Medicare Advantage is the privatized version of Medicare in which insurers like UnitedHealth, Humana, and CVS-Aetna receive per-enrollee payments from the federal government. CMS, HHS Inspector General, and DOJ investigations have repeatedly found that insurers inflate diagnosis codes to extract higher payments — a practice known as 'upcoding' — costing taxpayers an estimated $40 billion or more per year. The industry lobbies hard against rate cuts and audit rule changes.